Market Place
Sourcing Support
Klotho Neurosciences Secures Australian Patent for s-KL Protein
18 Feb 2026 //
PR NEWSWIRE
Klotho Neurosciences To Present At The Biotech Showcase 2026
08 Jan 2026 //
PR NEWSWIRE
Klotho Neurosciences Wins 2025 Biotech Breakthrough Award
07 Nov 2025 //
PR NEWSWIRE
Klotho Neurosciences Announces Expiration Of Letter Of Intent
07 Oct 2025 //
PR NEWSWIRE BIO
Klotho Neurosciences To Acquire Turn Biotech Assets In $300m
30 Sep 2025 //
PR NEWSWIRE
Klotho Shareholder Update Targets $8B Neuro Market
18 Aug 2025 //
PR NEWSWIRE
Klotho Neuro Begins KLTO-202 Production Using AAVnerGene`s Tech
12 Aug 2025 //
PR NEWSWIRE
Klotho Expands Pipeline Beyond Neurology
25 Jul 2025 //
PR NEWSWIRE
Klotho Neurosciences Expands Programs Beyond Neurology
24 Jul 2025 //
PR NEWSWIRE
Klotho Neurosciences, AAVnerGene Partner on Gene Therapy Assets
22 Jul 2025 //
PR NEWSWIRE
Klotho Neurosciences Regains Full NASDAQ Compliance
16 Jul 2025 //
PR NEWSWIRE
FDA grants Klotho Neurosciences orphan drug status for ALS
11 Jul 2025 //
PR NEWSWIRE
Klotho Neurosciences Advances Gene Therapy for ALS Treatment
30 Jun 2025 //
PR NEWSWIRE
Klotho to Study Longevity Gene in Okinawa’s Blue Zone
24 Jun 2025 //
PR NEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.